![Western Blot: eIF2 alpha/EIF2S1 [p Ser51] Antibody (RM298) [NBP2-61573] - HeLa cell lysate nontreated (-) or treated (+) with Calyculin A (CalA), using NBP2-61573.](http://images.novusbio.com/fullsize/eIF2-alpha-EIF2S1-p-Ser51-Antibody-RM298-Western-Blot-NBP2-61573-img0007.jpg "Western Blot: eIF2 alpha/EIF2S1 [p Ser51] Antibody (RM298) [NBP2-61573] - HeLa cell lysate nontreated (-) or treated (+) with Calyculin A (CalA), using NBP2-61573.")
| Reactivity | Hu, PoSpecies Glossary |
| Applications | WB, IHC |
| Clone | RM298 |
| Clonality | Monoclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Additional Information | Recombinant Monoclonal Antibody. |
| Immunogen | A phospho-peptide corresponding to Human eIF2 alpha/EIF2S1 [p Ser51] |
| Modification | p Ser51 |
| Specificity | This antibody reacts to human eIF2 alpha/EIF2S1 only when phosphorylated at Ser51. There is no cross-reactivity to eIF2 alpha/EIF2S1 without phosphorylation at Ser51. |
| Isotype | IgG |
| Clonality | Monoclonal |
| Host | Rabbit |
| Gene | EIF2S1 |
| Purity | Protein A purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
|
| Publications |
|
| Storage | Store at -20C. Avoid freeze-thaw cycles. |
| Buffer | 50% Glycerol/PBS, 1% BSA |
| Preservative | 0.09% Sodium Azide |
| Purity | Protein A purified |
![Western Blot PKLR Antibody [Unconjugated]](https://images.novusbio.com/images2/PKLR_AF8519_Western_Blot_16592.jpg)
![Simple Western PKLR Antibody [Unconjugated]](https://images.novusbio.com/images2/af8519_human-mouse-rat-pklr-affinity-purified-pab-simple-western-1342022154119.jpg)
Secondary Antibodies |
Isotype Controls |
Research Areas for eIF2 alpha/EIF2S1 Antibody (NBP2-61573)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | EIF2S1 |
![Immunohistochemistry-Paraffin: eIF2 alpha/EIF2S1 [p Ser51] Antibody (RM298) [NBP2-61573] - Human thyroid cancer tissue section using NBP2-61573.](http://images.novusbio.com/fullsize/eIF2-alpha-EIF2S1-p-Ser51-Antibody-RM298-Immunohistochemistry-Paraffin-NBP2-61573-img0005.jpg "Immunohistochemistry-Paraffin: eIF2 alpha/EIF2S1 [p Ser51] Antibody (RM298) [NBP2-61573] - Human thyroid cancer tissue section using NBP2-61573.")
![Immunohistochemistry-Paraffin: eIF2 alpha/EIF2S1 [p Ser51] Antibody (RM298) [NBP2-61573] - Human breast cancer tissue section using NBP2-61573.](http://images.novusbio.com/fullsize/eIF2-alpha-EIF2S1-p-Ser51-Antibody-RM298-Immunohistochemistry-Paraffin-NBP2-61573-img0003.jpg "Immunohistochemistry-Paraffin: eIF2 alpha/EIF2S1 [p Ser51] Antibody (RM298) [NBP2-61573] - Human breast cancer tissue section using NBP2-61573.")
![Western Blot SOS2 Antibody [Unconjugated]](https://images.novusbio.com/images2/SOS2_AF6260_Western_Blot_9542.jpg)
![Western Blot eIF4E [p Ser209] Antibody](https://images.novusbio.com/images/eIF4E-[p-Ser209]-Antibody-Western-Blot-NB100-81898-img0009.jpg)
![Immunocytochemistry/ Immunofluorescence eIF4E [p Ser209] Antibody](https://images.novusbio.com/images/eIF4E-[p-Ser209]-Antibody-Immunocytochemistry-Immunofluorescence-NB100-81898-img0005.jpg)
![Immunohistochemistry-Paraffin eIF4E [p Ser209] Antibody](https://images.novusbio.com/images/eIF4E-[p-Ser209]-Antibody-Immunohistochemistry-NB100-81898-img0006.jpg)
![Western Blot PERK Antibody [Unconjugated]](https://images.novusbio.com/images2/PERK_AF3999_Western_Blot_5379.jpg)
![Knockout Validated PERK Antibody [Unconjugated]](https://images.novusbio.com/images2/PERK_AF3999_Knockout_Validated_22482.jpg)
![Western Blot PERK Antibody [Unconjugated]](https://images.novusbio.com/images/af3999_human-perk-affinity-purified-polyclonal-ab-4120241240258.jpg)
![Western Blot GCN2 [p Thr899] Antibody](https://images.novusbio.com/images2/GCN2_AF7605_Western_Blot_12440.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")